Cargando…
Pharmacokinetic Analysis of Omomyc Shows Lasting Structural Integrity and Long Terminal Half-Life in Tumor Tissue
SIMPLE SUMMARY: The maintenance of the structural integrity of therapeutic proteins in the target tissue is crucial to their proper function. In this study, we aimed to assess the in vivo stability of the therapeutic protein Omomyc in blood serum and tumor tissue in a xenograft mouse model of colore...
Autores principales: | Beaulieu, Marie-Eve, Martínez-Martín, Sandra, Kaur, Jastrinjan, Castillo Cano, Virginia, Massó-Vallés, Daniel, Foradada Felip, Laia, López-Estévez, Sergio, Serrano del Pozo, Erika, Thabussot, Hugo, Soucek, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913332/ https://www.ncbi.nlm.nih.gov/pubmed/36765784 http://dx.doi.org/10.3390/cancers15030826 |
Ejemplares similares
-
Blocking Myc to Treat Cancer: Reflecting on Two Decades of Omomyc
por: Massó-Vallés, Daniel, et al.
Publicado: (2020) -
Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanoma
por: Zacarías-Fluck, Mariano F., et al.
Publicado: (2023) -
BET inhibition is an effective approach against KRAS-driven PDAC and NSCLC
por: Jauset, Toni, et al.
Publicado: (2018) -
MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and Seeding
por: Massó-Vallés, Daniel, et al.
Publicado: (2022) -
Omomyc Reveals New Mechanisms To Inhibit the MYC Oncogene
por: Demma, Mark J., et al.
Publicado: (2019)